ISPOR 2026 Home
  • About
    • News Center
  • Program
    • Program
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Plenary Sessions
  • Exhibits & Sponsorship
    • Exhibitor Directory
    • Sponsors
    • Media Partners
  • Photo Gallery
large-circle

ISPOR 2026

Sunday, May 17 - Wednesday, May 20

  • Home
  • Events
  • Past Conferences
  • ISPOR 2026
  • Program
  • Program
  • Presentation
  • DISABILITY AND ADHERENCE TO GLP-1 RECEPTOR AGONISTS AND SGLT2 INHIBITORS AMONG U.S. ADULTS WITH DIABETES: EVIDENCE FROM THE MEDICAL EXPENDITURE PANEL SURVEY

    Mar 18, 2026, 21:38 PM
  • CHANGES IN GLP-1RA UTILIZATION TRENDS AMONG MALES AND FEMALES DURING 2019-2024: IMPACT OF SEMAGLUTIDE (WEGOVY) APPROVAL FOR CHRONIC WEIGHT MANAGEMENT

    Mar 18, 2026, 21:38 PM
  • ASSESSING THE REPRESENTATIVENESS OF SURVEY-ELIGIBLE INDIVIDUALS IDENTIFIED FROM A LARGE US NATIONAL CLAIMS DATABASE

    Mar 18, 2026, 21:38 PM
  • REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH EGFR-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCER

    Mar 18, 2026, 21:38 PM
  • UNDERSTANDING THE HEALTH-RELATED QUALITY OF LIFE BURDEN IN CHRONIC HEPATITIS DELTA INFECTION: A SYSTEMATIC LITERATURE REVIEW

    Mar 18, 2026, 21:38 PM
  • PATIENTS’ VIEWS ON PUBLIC SUPPORT MECHANISMS IN COELIAC DISEASE IN HUNGARY

    Mar 18, 2026, 21:38 PM
  • AI-ASSISTED QUALITATIVE DATA EXTRACTION AND EVIDENCE MAPPING IN AN UMBRELLA REVIEW

    Mar 18, 2026, 21:38 PM
  • A QUALITATIVE ANALYSIS OF RECENT NEW HEALTH TECHNOLOGY ASSESSMENT CASES AND EVALUATION TRENDS FOR THE ADOPTION OF NOVEL TECHNOLOGIES

    Mar 18, 2026, 21:38 PM
  • INCORPORATING REAL-WORLD EVIDENCE (RWE) USING A REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) AUGMENTS TRADITIONAL SLRS: CASE STUDY IN NON-SMALL-CELL LUNG CANCER (NSCLC)

    Mar 18, 2026, 21:38 PM
  • DOES EQ-5D-3L ADEQUATELY CAPTURE THE PSYCHOLOGICAL IMPACT OF SIGHT LOSS? - EVIDENCE REVIEW

    Mar 18, 2026, 21:38 PM
  • TWO-YEAR COST ANALYSIS OF RADICAL PROSTATECTOMY - INDEX PROCEDURES AND ADJUVANT THERAPIES

    Mar 18, 2026, 21:38 PM
  • LEVERAGING GENERATIVE AI AND MACHINE LEARNING FOR ROBUST REAL-WORLD COHORT DEFINITION AND PATIENT JOURNEY INSIGHTS IN HIV RESEARCH

    Mar 18, 2026, 21:38 PM
  • METHODOLOGICAL CHARACTERISTICS OF PHARMACOGENOMICS-INTEGRATED AI CLINICAL DECISION SUPPORT SYSTEMS (AI-CDSS): A SYSTEMATIC REVIEW

    Mar 18, 2026, 21:38 PM
  • ASSOCIATIONS OF GESTATIONAL DIABETES TREATMENT WITH MATERNAL WEIGHT CHANGE AND NEWBORN BIRTHWEIGHT

    Mar 18, 2026, 21:38 PM
  • REAL WORLD INSIGHTS INTO OBESITY CARE: UNDERSTANDING TREATMENT PATTERNS AND PAYER COSTS AT AN INTEGRATED HEALTH SYSTEM

    Mar 18, 2026, 21:38 PM
  • APTITUDE TOWARDS PATIENT-CENTERED CARE AMONG PHYSICIANS MANAGING RARE DISEASES IN THE UNITED STATES: A CROSS-SECTIONAL SURVEY

    Mar 18, 2026, 21:38 PM
  • THE ECONOMIC BURDEN ON FAMILIES OF CHILDREN WITH TYPE 1 SPINAL MUSCULAR ATROPHY IN BRAZIL

    Mar 18, 2026, 21:38 PM
  • PHYSICIAN INSIGHTS ON CIDP CARE IN CANADA: UNMET NEEDS, ACCESS BARRIERS, AND EFGARTIGIMOD SC

    Mar 18, 2026, 21:38 PM
  • REAL-WORLD CLINICAL CHARACTERISTICS AND FACTORS ASSOCIATED WITH CONCURRENT GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1 RA) THERAPY AMONG PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) PRESCRIBED RESMETIROM

    Mar 18, 2026, 21:38 PM
  • INCLUSIVE HEALTH RESEARCH IN THE PALM OF YOUR HAND: THE EVIDATION EVERYONE REGISTRY

    Mar 18, 2026, 21:38 PM
  • «
  • 11
  • 12
  • 13 (current)
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group